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hTATE-OF-THE-ART PAPER1167Heart Failure in Hispanicsey P. Vivo, Selim R. Krim, Cihan Cevik, Ronald M. Witteles
ispanics comprise the largest and fastest-growing ethnic group in the U.S., with some data
ndicating that this group may be particularly vulnerable to developing heart failure (HF).
pidemiologic studies demonstrate that Hispanics have high rates of diabetes, obesity,
yslipidemia, and metabolic syndrome; all of these factors which may predispose to HF.
ispanics encounter multiple barriers to health care including socioeconomic, linguistic, and
ultural factors which may adversely impact disease prognosis. Vivo and colleagues argue that
ecognition of the predominant risk factors and health care disparities in this population is
rucial to tailoring appropriate management strategies.CLINICAL RESEARCH NTERVENTIONAL CARDIOLOGY
1176emporal Trends in Risk for Stent
Thrombosis in Patients After Left Main Stentingullio Palmerini, Antonio Marzocchi, Corrado Tamburino, Imad Sheiban, Massimo Margheri,
iuseppe Vecchi, Giuseppe Sangiorgi, Andrea Santarelli, Antonio L. Bartorelli, Carlo Briguori,
uigi Vignali, Francesco Di Pede, Angelo Ramondo, Luigi Inglese, Marco De Carlo, Leonardo Bolognese,
lberto Benassi, Cataldo Palmieri, Vincenzo Filippone, Diego Sangiorgi, Fabio Barlocco, Giulia Lauria,
tefano De Servi
almerini and colleagues investigated whether there is a temporal pattern of ischemic events
n patients who undergo percutaneous coronary intervention (PCI) for unprotected left main
oronary artery (ULMCA) stenosis. Of almost 900 patients who underwent ULMCA
tenting, the 30-day incidence of cardiac mortality and myocardial infarction (MI) was 5.4%.
n patients who remained on dual antiplatelet therapy, the risk of cardiac mortality and MI in
he time interval of 31 to 180 days was 3.6 times higher than compared to the time interval
f 181 to 360 days after PCI. This risk was driven almost entirely by patients presenting with
cute coronary syndromes. After stopping clopidogrel, the risk of the primary end point was
.2 times higher in the subsequent 90 days than for the 90 days prior. In patients with
LMCA stenosis who undergo PCI and survive the first 30 days, the risk for death or MI is
ighest in the first 6 months or in the first 90 days after stopping clopidogrel.(continued on page A-24)
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hEART RHYTHM DISORDERS1182Identifying> Factors That May Underlie Lone AFEditorial Commentartin K. Stiles, Bobby John, Christopher X. Wong, Pawel Kuklik, Anthony G. Brooks, Dennis H. Lau,
any Dimitri, Kurt C. Roberts-Thomson, Lauren Wilson, Paolo De Sciscio, Glenn D. Young,
rashanthan Sanders
he natural history of paroxysmal atrial fibrillation (AF) is one of increasing frequency and
uration of episodes. Stiles and colleagues hypothesized that patients with paroxysmal “lone”
F have an abnormal atrial substrate that underlies disease progression. Twenty-five patients
ith lone AF who had been free of AF for at least 1 week were studied. Compared with a
ontrol group without AF, subjects with AF had larger atrial volumes, longer effective
efractory periods, longer conduction time along linear catheters, greater proportion of
ractionated electrograms, and lower voltage. These structural and electrical differences are
ikely contributors to the “second factor” that predisposes to the development and progression
f AF.ARDIAC IMAGING1194CMR Can Identify Acute Ischemia Prior to InfarctionEditorial Commentassan Abdel-Aty, Myra Cocker, Cheryl Meek, John V. Tyberg, Matthias G. Friedrich
uring myocardial ischemia, myocytes swell due to failure of energy-regulated membrane
hannels. If ischemia persists, cell membranes disintegrate marking the onset of actual
ecrosis. Abdel-Aty and colleagues hypothesized that cardiac magnetic resonance (CMR)
maging, optimized for water content, could identify the cellular edema associated with
schemia. Fifteen dogs were studied with serial T2-weighted and cine imaging at baseline,
uring transient coronary occlusion, and after reperfusion. After approximately 30 min of
schemia, there were areas of high T2 signal intensity matching areas with new onset regional
kinesia. This preliminary study provides evidence that imaging myocardial edema using T2-
eighted CMR can detect acute myocardial ischemia before irreversible injury ensues.ARDIAC IMAGING
1204RI Myocardial Strain Assessment
Identifies Early Damage in Patients With DMDan N. Hor, Janaka Wansapura, Larry W. Markham, Wojciech Mazur, Linda H. Cripe, Robert Fleck,
. Woodrow Benson, William M. Gottliebson
uchenne muscular dystrophy (DMD) results from a mutation in the dystrophin gene; it
esults in progressive skeletal muscle weakness, with death secondary to cardiac or respiratory
ailure. The severity of the cardiomyopathy does not correlate to the severity of skeletal
uscle weakness, and early manifestations of heart failure in DMD patients often go
nrecognized. Hor and colleagues hypothesized that left ventricular myocardial peak
ircumferential strain (cc) would detect subclinical cardiac dysfunction in patients with
MD. Young DMD patients with normal ejection fraction (EF) had reduced cc compared
o control subjects. cc declined with age in patients with DMD and was further
ompromised in patients with reduced EF. Myocardial strain abnormalities are detectable in
oung DMD patients with preserved EF; this modality may help to understand the natural
istory of cardiac dysfunction in DMD patients.
(continued on page A-25)
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bULMONARY HYPERTENSION1211CRP> May Be a Useful Biomarker in Patients With Pulmonary HypertensionControl PAH CTEPH
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)ozenn Quarck, Tim Nawrot, Bart Meyns, Marion Delcroix
he importance of inflammation in the pathogenesis of pulmonary arterial hypertension
PAH) has only recently been investigated. Quarck and colleagues performed a retrospective
eview of C-reactive protein levels in almost 200 patients with either PAH or chronic
hromboembolic pulmonary hypertension (CTEPH). Circulating C-reactive protein (CRP)
evels were almost 2 times higher than control subject for both CTEPH and PAH patients.
n PAH patients, CRP levels correlated with New York Heart Association functional class,
ight atrial pressure, 6-min walk distance, and survival. In CTEPH patients, circulating CRP
evels decreased after pulmonary endarterectomy. This is the first evidence of a role of an
nflammatory marker in predicting outcome and response to therapy in PAH.PRE-CLINICAL RESEARCH RE-CLINICAL RESEARCH1219Mouse Knockout Model Not Susceptible to Coxsackie MyocarditisEditorial Comment
Kirk U. Knowlton andu Shi, Chen Chen, Ulrike Lisewski, Uta Wrackmeyer, Michael Radke, Dirk Westermann, Martina Sauter,
arsten Tschöpe, Wolfgang Poller, Karin Klingel, Michael Gotthardt
hi and colleagues used a conditional knockout (KO) mouse to evaluate the role of the
oxsackievirus-adenovirus receptor (CAR) in Coxsackievirus-mediated myocarditis. The
onditional KO allowed normal cardiogenesis, but inhibited expression of the CAR protein to
10% of wild-type (WT) controls after exposure to tamoxifen for 2 weeks. KO and WT
ice were then exposed to the virus. KO mice had virtually no evidence of infection; there
ere no structural changes, such as monocyte infiltration and fibrosis, no increased production
f interleukin-6 and -10, and no reduction in contractile function. Elimination of CAR in
dult hearts can efficiently block virus entry and the associated pathology of Coxsackievirus-
mediated myocarditis.RE-CLINICAL RESEARCH1229No Long-Term Survival for Transplanted Resident CSCsongjin Li, Andrew Lee, Mei Huang, Hyung Chun, Jaehoon Chung, Pauline Chu, Grant Hoyt,
hillip Yang, Jarrett Rosenberg, Robert C. Robbins, Joseph C. Wu
i and colleagues used a line of transgenic mice which constitutively express both the firefly
uciferase (Fluc) and enhanced green fluorescence protein (eGFP) genes, to study both the
linical benefit from and long-term survival of transplanted cardiac stem cells (CSCs). Cells
erived from these mice provide the advantage of being “trackable” over time. CSCs were
uccessfully isolated, engrafted, and imaged for bioluminescence. However, after 8 weeks,
here was no evidence for donor cell survival, and there were no differences in cardiac function
r viability as assessed by multiple imaging modalities or hemodynamic measurement. In this
ouse myocardial infarction model, there is no long-term engraftment of CSCs and no
enefit to cardiac function.
